Company Search:
Advanced Search
Sponsored Links
Immunovia AB (publ) Company Snapshot
Immunovia AB (publ) operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immunovia AB (publ) with three other miscellaneous service companies in Europe: Targovax ASA of Norway (2017 sales of 37,000.00 Norwegian Kroner [US$4,589.48 ] ), Silence Therapeutics Plc of the United Kingdom (£16,000.00 [US$21,505.44 ] ), and Oryzon Genomics Sa which is based in Spain (16,764.00 Euro [US$19,745.65 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Immunovia AB (publ)
  Stock Performance Chart for Immunovia AB (publ)
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 187.20
(Figures in Swedish Kronor)
1 Week 14.1%   13 Weeks 39.7%  
4 Weeks 110.1%   52 Weeks 75.4%  
Immunovia AB (publ) Key Data:
  Ticker: IMMNOV Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 148,963
(Year Ending Jan 2018).
Employees: 34
  Currency: Swedish Kronor Market Cap: 3,241,940,645
  Fiscal Yr Ends: December Shares Outstanding: 17,318,059
  Share Type: Aktie Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.